- Reports
- Lisa Graves
- Mary Bottari
- Wendell Potter
- Brendan Fischer
- Rebekah Wilce
- Sara Jerving
- Harriet Rowan
- Jonathan Rosenblum
- Will Dooling
- Emily Osborne
- Abdul Raziq
- Guest Contributor
- Archives
- Alex Carlin
- Anne Landman
- Bob Burton
- Chelsea Lawliss
- Diane Farsetta
- Eric Carlson
- Jennifer Page
- Jessica Opoien
- Jill Richardson
- John Stauber
- Judith Siers-Poisson
- Maxwell Abbott
- Megha Desai
- Monica Chang
- Osasumwen Izevbigie
- Patrick Moran
- Rebecca Sandler
- Ross Wolfarth
- Sarah Olson
- Sheldon Rampton
- Steve Horn
- Take Action
- Latest News
- Media
- SourceWatch
- Publications
- About Us
- Why Donate?
Retail Research Is Hurting Science
"The biggest threat to science," writes Jennifer Washburn, is "the decline of government support ... and the growing dominance of private spending over American research." In 1965, the U.S. government funded more than 60 percent of research, while in 2006, 65 percent of research was privately funded. Even some industry leaders are concerned that basic research, which "drives innovation 10 to 15 years out," is being shortchanged in favor of applied research focused on marketable products. Multiple analyses have shown "that the effect of industry funding on the research outcome is huge" -- a particularly troubling phenomenon for medical research. "Big Pharma now finances approximately 70 percent of the nation's clinical drug research," and of that, "an estimated 75 percent flows to for-profit contract research firms. ... In 2001, the editors of 12 leading medical journals ... expressed their shock at what was happening to independent scientific inquiry." Government research is increasingly privatized to firms like Sciences International, while "most of these federal agencies lack even the most rudimentary tools that a medical journal editor would use to assess the quality and scientific integrity of industry-funded research."
Main Source:
Discover magazine, October 11, 2007 



